On Monday, Janux Therapeutics Inc (NASDAQ: JANX) was 6.01% up from the session before settling in for the closing price of $29.94. A 52-week range for JANX has been $28.92 – $71.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 32.33%. When this article was written, the company’s average yearly earnings per share was at -41.20%. With a float of $49.57 million, this company’s outstanding shares have now reached $59.06 million.
Let’s determine the extent of company efficiency that accounts for 81 employees. In terms of profitability, gross margin is 90.2%, operating margin of -933.58%, and the pretax margin is -651.62%.
Janux Therapeutics Inc (JANX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Janux Therapeutics Inc stocks. The insider ownership of Janux Therapeutics Inc is 16.13%, while institutional ownership is 107.90%. The most recent insider transaction that took place on Mar 06 ’25, was worth 11,453,023. In this transaction Director of this company bought 372,093 shares at a rate of $30.78, taking the stock ownership to the 10,031,081 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Director bought 341,742 for $30.64, making the entire transaction worth $10,471,352. This insider now owns 9,658,988 shares in total.
Janux Therapeutics Inc (JANX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -41.20% per share during the next fiscal year.
Janux Therapeutics Inc (NASDAQ: JANX) Trading Performance Indicators
You can see what Janux Therapeutics Inc (JANX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 59.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 177.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -2.32 in one year’s time.
Technical Analysis of Janux Therapeutics Inc (JANX)
Looking closely at Janux Therapeutics Inc (NASDAQ: JANX), its last 5-days average volume was 0.78 million, which is a drop from its year-to-date volume of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 50.78%. Additionally, its Average True Range was 1.87.
During the past 100 days, Janux Therapeutics Inc’s (JANX) raw stochastic average was set at 6.59%, which indicates a significant decrease from 81.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.81% in the past 14 days, which was lower than the 90.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.91, while its 200-day Moving Average is $44.99. However, in the short run, Janux Therapeutics Inc’s stock first resistance to watch stands at $32.45. Second resistance stands at $33.15. The third major resistance level sits at $34.31. If the price goes on to break the first support level at $30.59, it is likely to go to the next support level at $29.43. Should the price break the second support level, the third support level stands at $28.73.
Janux Therapeutics Inc (NASDAQ: JANX) Key Stats
There are 59,105K outstanding shares of the company, which has a market capitalization of 1.88 billion. As of now, sales total 10,590 K while income totals -68,990 K. Its latest quarter income was 440 K while its last quarter net income were -28,060 K.
